Navigation Links
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Date:10/30/2007

PITTSBURGH, Oct. 30 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel. As Global General Counsel, Mr. Haggerty will manage and oversee all legal issues and the provision of legal services, counsel and advice globally to all members of Mylan's senior management in their various roles across the Company.

Mr. Haggerty joins Mylan from Sanofi-Aventis U.S. Inc. where he served as Vice President, General Counsel, and Corporate Secretary. He joined Sanofi-Aventis after serving as Vice President and General Counsel for U.S. Commercial Operations at Aventis Pharmaceuticals, which was acquired by Sanofi in 2004. Prior to joining Aventis, Mr. Haggerty served as Head of the Product Liability Group at Warner-Lambert Company and, prior to that, he practiced for nine years at Shearman & Sterling LLP. Mr. Haggerty joins Mylan with 23 years of litigation, commercial, and regulatory experience, including 14 years in the pharmaceutical sector.

Mylan Vice Chairman and CEO Robert J. Coury said: "In Joe, Mylan is adding yet another highly qualified, top-caliber individual to bolster our broad and deep senior management team. His broad-based litigation experience, strong background in the pharmaceutical industry, and previous experience integrating two legal departments in a post-merger environment make him uniquely qualified for this position at Mylan."

Mr. Haggerty said: "I am thrilled to be joining Mylan at this exciting time in the Company's history. I look forward to joining the already impressive global management team and supporting them and their operations with my counsel as Mylan becomes one of the leading qual
'/>"/>

SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...A cleanroom manufacturing company has introduced a...he feature is a utility panel which can be integra...nroom appearance. , Burns...eering, a designer, fabricator and installer of cl... offering a utility panel for integration into its...
(Date:7/24/2008)...swire-FirstCall/ --, Key Highlights, Misys plc (...nd is now,raising targets for the next phase of th... GBP492m up 6%, bringing Group operating profit(2)...ting on its strategy and entering,into the next ph...r growth., To view the Multimedia News Release, p...
(Date:7/23/2008)...d for better physician-administration relations ...sicians, SOUTH BEND, Ind., July 24 /PRNewswire/ -...eport: Physician Perspectives on American Hospital...ysician-administration,relationship, and physician...onsive to the ideas and needs of medical staff. Th...
(Date:7/23/2008)... welcome to out-of-state intended parents, SAN RA...lifornia,Supreme Court decision to allow gay coupl...oductive Science Center of the Bay Area (RSC), one...rving gays and lesbians for,infertility treatment.... supports RSC,s,long-held views that procreation i...
Breaking Medicine News(10 mins):Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Authoritative Report on Physician Perspectives Released Today 2Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2
...Leire Garca Navarro, a researcher at the School of... hopes for patients suffering colon and liver canc...ing the growth of such cancers. This discovery i...ral dissertation, entitled Lipo-Polymeric Vectors ...
...bouts of nausea and vomiting during their pregnanc...it but it seems that going through morning sicknes...o have conducted a new study and found that women ...ve a 30 percent lower risk of developing breast ca...
...oking rate has shown a decline, thanks to the comp...kick the habit. The statistics in the 2006 report...mparison to 2002 figures. Over the past year, smok... to 19.9%) and among Hispanics (from 20.2% to 17.1...
...r on switch triggers gene activity that cause eff... to glucose production in the liver was discovere...spital . The on switch, a protein called CREB, is...binds to a section of DNA near a gene and triggers...
Other Medicine News:Health News:Novel Treatment Beneficial for Colon and Liver Cancer 2Health News:Morning Sickness may Signify Lower Breast Cancer Risk 2Health News:Morning Sickness may Signify Lower Breast Cancer Risk 3Health News:New York Records Decline in Smoking Rate 2Health News:Research Studies on Molecular Switches of Gene 2
(Date:7/22/2008)...Regimens Including Lantus(R) and Apidra(R) Resulte...th Type 2 Diabetes, Whatever the Algorithm ..., July 22 /- Results from the "Adjust...ple Algorithm to Carbohydrate,Counting for Adjustm...lished in the American Diabetes Association,s (ADA...
(Date:7/22/2008)...veloped and Validated by Columbia University Medic...prietary MicroRNA Technology, The Test Different...ng Cancer (NSCLC), Classifying Squamous-Cell Carc...rcent and Specificity of 90 Percent,This is the Fi...Sensitivity as Biomarkers for Accurate Di...
(Date:7/22/2008)...ot Study Suggests That Ekkyo,s New Approach of LAS...y Improve Scar Healing Physiology, MARSEILLES, Fr...n as,Heatwave Technology) a photomedicine company,... for skin scar prevention and reduction, announced...Lasers in Surgery and Medicine*,reporting the resu...
(Date:7/21/2008)...DON, July 21 /- The SEAS (Simvastatin...tigated the effects of intensive,cholesterol lower...ly) and,ezetimibe (10 mg daily) in patients with a...partial blockage of the aortic valve in,the heart)... in Western,populations. Left untreated, it can pr...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4Liver transplant offers survival benefits for patients of all sizes 7546 1Liver transplant offers survival benefits for patients of all sizes 7546 2Liver transplant offers survival benefits for patients of all sizes 7546 32 in 1 Test Signals Risk After Heart Attack 7543 12 in 1 Test Signals Risk After Heart Attack 7543 22 in 1 Test Signals Risk After Heart Attack 7543 3HealthCentral coms New Stop Smoking Site Provides Expert Advice Supportive Community to Help Smokers Quit 7539 1HealthCentral coms New Stop Smoking Site Provides Expert Advice Supportive Community to Help Smokers Quit 7539 2Dietitians Urge Parents to Serve Milk With Meals 7535 1Dietitians Urge Parents to Serve Milk With Meals 7535 2Dietitians Urge Parents to Serve Milk With Meals 7535 3
...ard/Conventional Blade. Stainless Steel. Lamp supp... of high quality standard incandescent laryngoscop...ntinually refined through many years of use the wo...y are manufactured to exacting specifications from...
... Snap-Light™ laryngoscope blades are designe...iber optic bundle can be removed to simplify clean...ue snap-on mechanism eliminates screws that can be...ngeable with other green coded fiber optic systems...
...spec Laryngoscopes are a high quality fiberoptic s...r standardization to fiberoptic laryngoscopes. The...d indicates it's ability to interconnect with othe...t offers a cool, bright and focused light. The Gre...
...spec Laryngoscopes are a high quality fiberoptic s...r standardization to fiberoptic laryngoscopes. The...d indicates it's ability to interconnect with othe...t offers a cool, bright and focused light. The Gre...
Medicine Products: